Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Tables)

v3.24.2.u1
STOCKHOLDERS' EQUITY (Tables)
6 Months Ended
Jun. 30, 2024
STOCKHOLDERS' EQUITY  
Schedule of Restricted Stock Unit activity

Weighted Average

Weighted Average

Remaining Contractual

    

Amount

    

Grant Date Fair Value

    

Life (Years)

Outstanding at December 31, 2023

532,399

$

14.82

1.84

Granted

1,145,530

 

-

Forfeited

(56,119)

 

-

Vested

(217,843)

-

Outstanding June 30, 2024

1,403,967

$

8.51

2.42

Weighted Average

Weighted Average

Remaining Contractual

    

Amount

    

Grant Date Fair Value

    

Life (Years)

Outstanding at December 31, 2022

1,374,383

$

10.72

$

2.88

Granted

359,993

 

15.00

2.55

Forfeited

(15,699)

15.24

2.20

Vested

(134,641)

14.43

-

Outstanding June 30, 2023

1,584,036

$

11.34

$

3.06

Schedule of options granted

    

Grant Date

June 7, 2024

Risk-free interest rate

 

4.42%

Expected volatility of common stock

 

50.04%

Dividend yield

 

-

Expected option term in years

 

6.0

Grant-date fair value (per share)

$

3.73

Schedule of Stock options activity

    

    

    

    

Weighted Average

    

    

Weighted average

Remaining Contractual

Aggregate Intrinsic

Shares

Exercise price per share

Life (Years)

 Value (1)

Outstanding at December 31, 2023

 

-

$

-

 

-

 

-

Granted

 

644,550

 

7.02

 

10

 

-

Forfeited

 

-

 

-

 

-

 

-

Exercised

 

-

 

-

 

-

 

-

Outstanding June 30, 2024

 

644,550

 

7.02

 

10

 

-

Nonvested at June 30, 2024

 

644,550

 

7.02

 

10

 

-

Exercisable

 

-

 

-

 

-

 

-

(1) Total shares valued at the market price of the underlying stock as of June 30, 2024 less the exercise price.